Conversational Agents to Improve HPV Vaccine Acceptance in Primary Care (ECA-HPV)- Clinical Trial

Description

The objective of this study is to assess the use of and satisfaction with the ECA-HPV intervention over a 16-month period, its ability to increase HPV vaccination, and the comparative effectiveness of clinic notification and adolescent ECA components on these factors.

Conditions

Human Papilloma Virus

Talk to us

Study Overview

On this page

Study Details

Study overview

The objective of this study is to assess the use of and satisfaction with the ECA-HPV intervention over a 16-month period, its ability to increase HPV vaccination, and the comparative effectiveness of clinic notification and adolescent ECA components on these factors.

Conversational Agents to Improve HPV Vaccine Acceptance in Primary Care

Conversational Agents to Improve HPV Vaccine Acceptance in Primary Care (ECA-HPV)- Clinical Trial

Condition
Human Papilloma Virus
Intervention / Treatment

-

Contacts and Locations

Boston

Boston Medical Center, Boston, Massachusetts, United States, 02118

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • 1. Speaks English fluently
  • 2. Able to independently consent
  • 3. Has adequate corrected vision to use the ECA-HPV system (based on their ability to go through the consent form)
  • 4. Has adequate hearing to use the ECA-HPV system (based on their ability to hear the research staff member conducting the consent process)
  • 5. Has a smartphone that is able to support the ECA-HPV app
  • 1. Is between the ages of 9-12 at the time of the index (first) well child visit
  • 2. Has received either 1 or none of the HPV vaccine series
  • 3. Speaks English fluently
  • 4. Able to independently assent
  • 5. Has adequate corrected vision to use the ECA-HPV system
  • 6. Has adequate hearing to use the ECA-HPV system
  • 7. Has a smartphone or has access to parent/guardian's smartphone (that is able to support the ECA-HPV app)
  • 8. Has an upcoming well child visit at Boston Medical Center
  • 1. Is not able to use the ECA-HPV system
  • 2. Has already participated in the study before

Ages Eligible for Study

8 Years to 12 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Tufts Medical Center,

Michael Paasche-Orlow, MD, MPH, PRINCIPAL_INVESTIGATOR, Tufts Medical Center

Study Record Dates

2027-12